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Limited data are available on the cellular and immunocytological characteristics of bronchoalveolar lavage (BAL)
fluid in individuals infected with the human immunodeficiency virus (HIV) and pulmonary tuberculosis (TB). The
immune host response against tuberculosis in early HIV-infection may dier from that in later stages of HIV
disease, as is strongly suggested by dierent clinical and radiographic patterns. We studied the cellular elements in
the lungs of 15 HIV-infected patients with advanced immunosuppression and pulmonary tuberculosis (TB/AIDS). The
findings were compared with data from four other groups: 1) 15 HIV-seronegative patients with pulmonary TB; 2)
12 HIV-seropositive TB patients without previous AIDS-defining illnesses and with CD4+4200 cells mm73; 3)
five AIDS patients without pulmonary lesions; and 4) five healthy controls. BAL fluid and dierential cell counts,
as well as lymphocyte subsets, were determined. Despite a low CD4/CD8 ratio, the TB/AIDS group had a higher
absolute number of CD8+ lymphocytes in the BAL fluid than the other groups. Alveolar macrophages and
neutrophils were significantly increased in TB/AIDS patients compared to control groups. The number of
eosinophils was increased in TB/HIV7patients but not in TB/AIDS patients. We conclude that tuberculosis in late
stage HIV-infected patients has a distinct inflammatory cell profile, suggesting an enhanced compensatory
mechanism that amplifies the unspecific inflammatory reaction.
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Human immunodeficiency virus type-1 (HIV-1) and My-
cobacterium tuberculosis co-infection are together an
important cause of morbidity and mortality worldwide
(1–3). Tuberculosis (TB) shortens the asymptomatic stage
of HIV-1 infection and reduces survival (4). HIV-induced
immunosuppression amplifies and accelerates the course of
TB (5). Although most opportunistic infections occur late
in the course of HIV-1 infection, TB often precedes these by
1 month to 2 yr (6). In early HIV-1 infection, when patients
are presumably more immunocompetent, TB is typical ofReceived 9 March 1999 and accepted in revised form 23 July 1999.
Correspondence should be addressed to: Dr. Eduardo Werneck-
Barroso, Servic¸o de Bacteriologia da Tuberculose - Instituto de
Doenc¸as do To´rax, UFRJ. Rua Carlos Seidl 813, Caju, RJ, Rio de
Janeiro, Brazil- CEP: 20931-000. Fax: +55 021 580-8532/+55 021
556-3348; e-mail: edwerneck@infolink.com.br
0954-6111/00/010064+07 $35?00/0reactivation with focal cavitary lung disease. In later stages
of HIV disease, pulmonary TB often presents with a diuse
alveolar and interstitial radiographic pattern with hilar
adenopathy, resembling progressive, primary disseminated
tuberculosis (7–10).
Bronchoalveolar lavage (BAL) has been used to char-
acterize the cellular elements in the lung (11,12). Several
studies demonstrated an increased number of pulmonary
CD4+lymphocytes and neutrophils in the BAL fluid of
patients with tuberculosis (13–16). However, limited data
has been presented based on samples from the lungs of
HIV-infected patients with TB (17,18). Moreover, there is
no information comparing cell profiles in early and late
stages of HIV disease. The cellular elements in the lungs of
TB patients in late HIV-1 disease may be dierent from
those in early stages, as is strongly suggested by dierent
clinical and radiographic patterns. Our aim was to assess
the cellular elements recruited into the lungs of AIDS
patients with advanced immunosuppression, before they# 2000 HARCOURT PUBLISHERS LTD
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compare them with HIV-seropositive TB patients without
previous AIDS-defining disease and HIV-seronegative TB
patients, both with typical pulmonary tuberculosis.
Materials and methods
SUBJECTS
Patients consecutively observed at the Lagoa Federal
Hospital of Rio de Janeiro, all of whom had bronchoscopy
performed for the diagnosis of pulmonary infiltrates, were
enrolled over the period from March 1990 to September
1994. Both patients and healthy volunteers, after giving
written informed consent, were asked to participate and to
submit to bronchoscopy with BAL. The study was
approved by the Committee of Human Subjects of the
Oswaldo Cruz Foundation.
A total of 47 patients were grouped by disease category
based on clinical, microbiological and HIV serological data
as: 1) 15 HIV-1 seronegative patients with pulmonary TB,
no cavitation and positive PPD skin test (TB/HIV7); 2) 12
HIV-1 seropositive patients with pulmonary TB without
cavitation, with positive PPD skin test, without previous
AIDS defining disease and with CD4+4200 cells mm73,
(TB/HIV+); 3) 15 patients with TB and AIDS (TB/AIDS)
with a history of two opportunistic infections and CD4+
counts less than 100 cells mm73 prior to the development of
tuberculosis; and 4) five AIDS patients with CD4+ counts
less than 100 cells mm73 who presented with a fever of
unknown origin (FUO), without respiratory symptoms or
pulmonary radiological abnormalities. All of these patients
had bronchoscopy requested by their primary physicians, in
order to exclude an unrevealed pulmonary process as part
of the diagnostic work-up for FUO, and were later
classified as a control AIDS group if no infectious or
non-infectious aetiology was detected in the BAL. All
AIDS patients had fulfilled the 1987 CDC clinical case
definition for AIDS (19) and had negative PPD skin tests.
None of the AIDS patients were receiving any anti-
retroviral treatment. A standardized questionnaire was
administered before the bronchoscopy procedure, in order
to obtain clinical and demographic information. For control
purposes, five healthy volunteers (healthy controls, HC)
seronegative for HIV-1 were recruited. All chest radiographs
were reviewed independently by two chest physicians who
were blinded to the clinical and laboratory information.
HIV SEROLOGY
After counselling and informed consent, blood was obtained
for an HIV-1 enzyme immunoassay (EIA, Organon Tekni-
ka, Durham, NC, U.S.A.) and confirmation by Western blot
(DuPont Medical Products, Wilmington, DE, U.S.A.).
BRONCHOALVEOLAR LAVAGE
Bronchoscopy with BAL was performed as described
(11,12). Briefly, after topical anesthesia of the upper airwaywith 1% lidocaine solution, a fiberoptic bronchoscope
(Olympus BF 20 bronchoscope) was introduced by the
transnasal route into the trachea and bronchi. After visual
evaluation of the airways, the tip of the bronchoscope was
wedged into the subsegmental bronchus of the involved
lung, or in the right middle lobe of the diusely involved
lung or even in the normal lung. For control purposes, the
cases in which the disease was identified as unilateral in
chest roentgenogram, a contralateral lavage was performed.
A total of 200 ml of sterile isotonic saline was injected in
aliquots of 20 ml. Fluid was recovered by controlled
aspiration into sterile siliconized glass vials, later pooled
and immediately processed for analysis. To avoid upper-
airway contamination, the first sample of BAL fluid was
collected separately and used only for microbiological
studies. Patients were excluded from the analysis after
bronchoscopy, because less than 50% of the BAL fluid
volume was recovered, more than 5% of the cells in the
BAL fluid were epithelial cells or the patient had evidence
of bronchitis on bronchoscopy (mucopurulent secretion,
overall swelling and increased vascularity of bronchial
mucosa, dilated ducts of mucus-secreting glands).
MICROBIOLOGIC STUDIES
Air-dried and fixed cytocentrifuged slides of BAL fluid were
prepared by Papanicolaou, Gram’s Ziehl-Neelsen, Gram-
Weigert and Gamer-methenamine silver-staining methods,
or immunofluorescent antibodies for Pneumocystis carinii
and cytomegalovirus, and were examined by a cytopathol-
ogist in order to delineate cell types for cell morphology
and microbes including bacteria, M. tuberculosis, Pneumo-
cystis carinii and viral inclusions (e.g. cytomegalovirus).
The BAL cell pellet and supernatant separated by
centrifugation (250 g, 10 min) were cultured in Sabouraud’s
and Mycosel agar, and in brain–heart infusion broth for
standard microbiological and fungal cultures. Mycobacter-
ial cultures on Lo¨wenstein–Jensen medium were incubated
for up to 2 months, and the presence of the M. tuberculosis
species was confirmed by biochemical tests.
ANALYSIS OF BAL FLUID AND
PERIPHERAL BLOOD CELLS
Total leukocyte counts in BAL fluid and in peripheral
blood were determined in a Neubauer chamber after being
diluted in saline with ZAP-globin (Coulter). Cell dierential
of cytocentrifuged preparation of BAL fluid and of
peripheral blood smear stained with May–Grunwald–
Giemsa dye was enumerated by microscopy under oil
immersion objective. Results were expressed as cell number ml71
of lavage fluid, total cells (multiplying cell number ml71
by total BAL fluid volume recovered) ml71 of peripheral
blood (mean numbers +SD). The T-cell subsets were
evaluated in BAL fluid and peripheral blood by flow
cytometry after incubation of the cells with fluorescent
isothiocyanate conjugate (FITC). Commercially available
monoclonal antibodies anti-CD4 and anti-CD8 (Beckton-
Dickenson) were used.
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The analysis of variance ANOVA and the Kruskal–Wallis
test or the Fisher’s exact test were used to test for
dierences between groups. Dierences between groups
were considered significant if considered if P5005.
Results
CHARACTERISTICS OF STUDY SUBJECTS
Table 1 summarizes demographic characteristics, HIV risk
factors, and peripheral blood CD4+ cell counts of the
studied groups. All groups were of similar age, gender
distribution and proportion of cigarette-smoking indivi-
duals. Comparable peripheral blood CD4+ cell counts
were observed between the TB/HIV7 and TB/HIV+
groups and between TB/AIDS and AIDS groups. There
was no significant dierence among TB/HIV7, TB/HIV+
and TB/AIDS patient groups in terms of frequency of fever,
cough (with or without sputum), chest pain, dyspnoea,
duration of illness and family or prior history of TB (data
not shown). On chest X-ray, TB/HIV7 and TB/HIV+
patients had non-cavitary upper lobes alveolar abnormal-
ities while all TB/AIDS patients had interstitial and diuse
radiographic changes and six (40%) TB/AIDS patients also
had hilar or paratracheal adenopathy.
CELL COUNTS, LYMPHOCYTE SUBSETS
AND PHAGOCYTES IN BAL FLUID
The number of cells recovered by BAL was highest
in patients with tuberculosis, 552+1376104 ml71
(TB/HIV7), 397+1056104 ml71 (TB/HIV+) and
413+1176104 ml71 (TB/AIDS) if compared to healthy
volunteers and AIDS patients, 198+576104 ml71 and
234+726104 ml71, respectively (P5001). The TB/TABLE 1. Characteristics of study groups, risk activities for H
lymphocytes
HC/HIV7 TB/H
Characteristics n=5 n=
Age* (years) 32+4 26
Sex (male/female) 4/1 12
Smoker 2 (40%) 8 (4
HIV risk activity
Homosexual –
Transfusion –
Heterosexual HIV+Partner –
IDU –
Unknown –
Peripheral blood
CD4 positive cells* 1060+320 650+
*mean+SD.HIV7 and TB/HIV+ patients had significantly higher
number of lymphocytes recovered from BAL fluid than
healthy controls (P5005). The TB/AIDS group had a
higher number of lymphocytes in the BAL fluid than the
AIDS group (P5001). However, the number of CD4+
cells in the BAL fluid from patients with TB/AIDS was
markedly reduced when compared to the TB/HIV7 or TB/
HIV+ groups. The TB/AIDS group had a higher absolute
number of CD8+ lymphocytes in the BAL fluid than
the other groups. Therefore, these patients had a very
low CD4/CD8 ratio (Table 2). Alveolar macrophages
were significantly increased in TB/AIDS patients
(322+586104 ml71) when compared to other groups:
18+636104 ml71 for TB/HIV+; 17+76104 ml71 for
TB/HIV7, and 17+76104 ml71 for the AIDS group
(P5001). Neutrophils were also significantly increased in
TB/AIDS patients (73+276104 ml71) when compared to
other groups: 39+076104 ml71 for TB/HIV+; 41+
046104 ml71 for TB/HIV7, and 07+026104 ml71
for AIDS group (P5001). The number of eosinophils was
significantly increased (P5005) only in the TB/HIV7
group, due to the presence of 3/15 (20%) patients with high
eosinophil counts (Fig. 1).
PERIPHERAL BLOOD CELL COUNTS
Peripheral blood lymphocyte counts were similar for
patient groups but were slightly lower than in healthy
control subjects (Fig. 2). All patient groups had similar
numbers of monocytes and eosinophils. The neutrophil
count in the TB/AIDS group was approximately 2-fold
higher than AIDS, TB or HC groups (P5005).
Discussion
In the present study, we showed that patients with both
pulmonary TB and AIDS (TB/AIDS) have a dierent cellIV acquisition, and peripheral blood CD4+ and CD8+
IV7 TB/HIV+ TB/AIDS AIDS
15 n=12 n=15 n=5
+7 31+6 32+5 31+4
/3 11/1 14/1 4/1
2%) 4 (33%) 7 (38%) 2 (40%)
– 9 11 4
– – 2 –
– 1 – 1
– – 1 –
– 1 1 –
370 450+210 55+30 78+48
TABLE 2. Bronchoalveolar lymphocytes and lymphocytes subsets by study groups
HC/HIV7 TB/HIV7 TB/HIV+ TB/AIDS AIDS
Cells (104 ml71) n=5 n=15 n=12 n=15 n=5
Total lymphocytes 14+03 172+51 145+63 92+22 35+10
CD4+ cells (%) 063+013 100+111 85+13 174+031 054+018
(45%) (58%) (58%) (19%) (15%)
CD8+ cells (%) 042+011 241+042 292+055 537+078 245+045
(30%) (14%) (20%) (58%) (70%)
CD4/CD8 ratio 15+03 41+08 29+08 032+015 021+012
*mean+SD.
FIG 1. Dierential cell counts in the bronchoalveolar lavage BAL fluid from five healthy controls (Healthy), 15 HIV-
seronegative patients with tuberculosis (TB/HIV7), 12 HIV-seropositive patients with tuberculosis (TB/HIV+), five
patients with AIDS who had fever and in whom infection was excluded by bronchoscopy (AIDS) and 15 patients with AIDS
and tuberculosis (TB/AIDS). Data are means+SD. Comparisons indicate statistical significant dierence,
(*)P5005;(**)P5001.
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seronegative patients with tuberculosis. We found a
significant lymphocyte accumulation (410-fold compared
with healthy volunteers) and a high CD4/CD8 ratio in the
lungs of TB/HIV7 and TB/HIV+ patients. TB/AIDS
patients had a low CD4/CD8 ratio. However, compared to
AIDS patients without pulmonary disease, TB/AIDS
patients had a 2-fold increase in CD8+ cells and a 3-fold
increase in CD4+ cells.
The absolute number of alveolar macrophages was
significantly increased in the BAL fluid of TB/AIDS
patients, relative to the other groups. This finding has notbeen previously reported. It is known that a dissociation
exists between macrophage accumulation and local chemo-
tactic activity in chronic inflammatory sites (20). With the
progression of immune system impairment, less granulo-
matous lesions are found in HIV infected patients (21,22).
However, although macrophages are not able to form
granulomas, they are actively recruited and accumulated in
the lesion.
Neutrophil accumulation has been well described in BAL
fluid from patients with pulmonary TB (13–16). We found
that neutrophil accumulation induced by M. tuberculosis in
HIV infected patients with advanced immunosuppression
FIG. 2. Dierential cell counts in the peripheral blood from five normal controls (Healthy), 15 HIV-seronegative patients
with tuberculosis (TB/HIV7), 12 HIV-seropositive patients with tuberculosis (TB/HIV+), five patients with AIDS, fever of
unknown origin and pulmonary lesion(s) (AIDS) and 15 AIDS patients with tuberculosis (TB/AIDS). Data are means+SD.
(*) Indicates a statistical significant dierence, P5005.
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early stage HIV seropositive patients with pulmonary TB.
The role of these cells has been reported as irrelevant for the
protection of the host against TB (22,23,24). Most studies
are based on in vitro assays of isolated neutrophils and little
is known about the in vivo responses. Although polymor-
phonuclear (PMN) cells have a short half-life in the aected
tissues (25), neutrophils had been described during the
inflammatory and exudative stages of tuberculosis (26).
Juvenile PMN band forming cells in blood was a common
observation in disseminated pulmonary tuberculosis in the
pre-antibiotic era (27). We have recently demonstrated that
a shift to the left in the white blood count is characteristic of
AIDS patients with bacteremic tuberculosis (28). In
experimental systems, disseminated tuberculosis induced
by interferon-g (IFN-g) gene-disrupted mice cause PMN
attraction (29,30). These findings implicate a continuous
chemotaxis and migration of neutrophils in immunosup-
pressed patients with tuberculosis. We can speculate that
PMN cells may be important in host response against M.
tuberculosis in this context.
Patients with TB had a significantly increased proportion
of eosinophils in BAL. Viijayan et al. (31) described three
(9%) eosinophilic pneumonia cases demonstrated by BAL
among 33 bacteriologically confirmed pulmonary tubercu-
losis patients. They also reported the disappearance of the
eosinophilic inflammatory process after anti-tuberculous
treatment. Ozaki et al. (16) also found a significantdierence in the number of eosinophils retrieved from
active pulmonary lesions and control groups. Unfortu-
nately, HIV serology was not performed in either study.
Although not statistically significant, the absence of a
similar proportion of TB/AIDS patients with elevated
eosinophil counts suggests that when eosinophil recruit-
ment is required in tuberculosis, CD4+ T cells are
involved.
Taking into account the macrophage and neutrophil
accumulation in patients with tuberculosis and advanced
AIDS as described above we suggest an enhanced
compensatory mechanism that amplifies the non-specific
inflammatory reaction. Our experience with the care of
severely immunosuppressed AIDS patients with tubercu-
losis is corroborated by autopsy studies which suggest that
the cause of death in these patients is usually not
tuberculosis itself, but other opportunistic infections
(32,33). This observation highlights the old idea that the
role of inflammatory response to M. tuberculosis is an
important disease control component (26). It is possible
that some individuals have the ability to cope with bacillary
load using non-specific or innate defense systems.
On the other hand, in view of severity of the tuberculosis
in some AIDS patients (34), our findings may provide
additional rationale to evaluate the use of anti-inflamma-
tory drugs concomitantly to anti-tuberculous treatment in
HIV infected patients with aggressive tuberculosis. There
are limited data (35) but some recommend (36) the
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patients with tuberculosis.
In conclusion, pulmonary TB in AIDS patients with
advanced immunosuppression, in addition to the expected
lower lymphocytes counts, also has a distinct inflammatory
cell profile. The impairment of CD4+ T cells modifies the
type and magnitude of recruited cells at sites of pulmonary
inflammation. These changes should be useful for under-
standing the pathogenesis of the chronic inflammatory
processes in AIDS patients.
Acknowledgements
This work was supported in part by National Institutes of
Health Grants R37-22624, D43-TW00018, and PO1
AII6282 (JLH). MGBA and ALK were supported in part
by a Fogarty Training Grant, D43-TW00018. We thank
Antonio Miguel M. da Costa, Marcus Conde, Patricia G.
Assis, Roberto A. Horta, Gisele B. Vieira, Anna Grazia
Marsico, Jaqueline Rodrigues de Oliveira and the nursing
sta of the Endoscopy Service of Lagoa Hospital for
technical support and services.
References
1. Dolin PJ, Raviglione MC, Kochi A. Global tubercu-
losis incidence and mortality during 1990–2000. Bull
World Health Organ 1994; 72: 213–220.
2. Zacarias F, Gonzales RS, Cuchi P, et al. HIV/AIDS
and its interaction with tuberculosis in Latin America
and the Caribbean. Bull Pan Am Health Organ 1994;
28: 312–323.
3. Raviglione MC, Snider DE, Kochi A. Global epide-
miology of tuberculosis. JAMA 1995; 273: 220–226.
4. Ho JL. Co-infection with HIV and Mycobacterium
tuberculosis: Immunologic interactions, disease pro-
gression, and survival. Mem Inst Oswaldo Cruz 1996;
91: 385–387.
5. Murray JF. The white plague: down and out,
or coming and up? Am Rev Respir Dis 1991; 144:
750–755.
6. Rieder HL, Cauthern GM, Bloch AB. Tuberculosis
and acquired immunodeficiency syndrome Arch Int
Med 1989; 149: 1268–1273.
7. Hopewell PC. Impact of Human Immunodeficiency
virus infection on the epidemiology, clinical features,
management, and control of tuberculosis. Clin Infect
Dis 1992; 15: 540–547.
8. Bennett D, Watson J. Tuberculosis in the immuno-
competent patient. Curr Top Infect Dis 1994; 7: 184–
191.
9. Khan MA, Kovnat DM, Bachus B, Whitcomb ME,
Broady JS, Snider DL. Clinical and roentgenographic
spectrum of pulmonary tuberculosis in the adult. Am J
Med 1977; 62: 31–38.
10. Kritski AL, Werneck-Barroso E, Bravo De Souza R,
Andrade GN, Castilho EA, Galva˜o-Castro B. Tuber-culosis and HIV infection in Rio de Janeiro, Brazil.
AIDS 1991; 5: 107–118.
11. Reynolds HJ, Newball HH. Analysis of proteins and
respiratory cells obtained from human lungs by
bronchial lavage. J Lab Clin Med 1974; 84: 559–573.
12. Hunninghake GW, Gadek JE, Kawanami O, Ferrans
VJ, Crystal RG. Inflammatory and immune processes
in the human lung in health and disease: evaluation by
bronchoalveolar lavage. Am J Pathol 1979; 97:
149–206.
13. Ainslie GM, Solomon JA, Baterman ED. Lymphocyte
and lymphocyte subset number in blood and in
bronchoalveolar lavage and pleural fluid in various
forms of human pulmonary tuberculosis at presenta-
tion and during recovery. Chest 1992; 102: 54–59.
14. Hoheisel GB, Tabak L, Teschler H, Erkan F, Krogel C,
Costabel U. Bronchoalveolar lavage cytology and
immunocytology in pulmonary tuberculosis. Am J
Respir Crit Care Med 1994; 149: 460–463.
15. Dhand R, Gaanguly NK, Gupta N, Jaswal S, Malik
SK, Kohlih KK. Factors influencing the cellular
response in bronchoalveolar lavage and peripheral
blood of patients with pulmonary tuberculosis. Tuber-
cle 1988; 69: 161–173.
16. Ozaki T, Nakahira S, Tani K, Ogushi F, Yasuoka S,
Ogura T. Dierential cell analysis in bronchoalveolar
lavage fluid from pulmonary lesions of patients with
tuberculosis. Chest 1993; 104: 1773–1778.
17. Law KF, Jagirdar J, Weiden MD, Bodkin M, Rom
WN. Tuberculosis in HIV-positive patients: cellular
response and immune activation in the lung. Am J
Respir Crit Care Med 1996; 153: 1377–1384.
18. Nowkowski M, Chan S-P, Steiner P, Chice S, Durkin
HG. Dierential distributions blood lymphocytes sub-
sets in pediatric AIDS or tuberculosis. Ann Clin Lab Sci
1992; 22: 377–384.
19. CDC Revision of CDC Surveillance Case Definition
for AIDS. MMWR 1987; 36: S3–15.
20. Jungi TW, McGregor DD. Dissociation of macrophage
accumulation and local chemotactic activity in delayed
inflammation sites. Cell Immunol 1979; 7: 274–284.
21. Chaisson RE, Schechter GF, Goodman PC et al.
Tuberculosis in patients with acquired immunodefi-
ciency syndrome. Am Rev Respir Dis 1987; 136:
570–574.
22. Barnes PF, Bloch AB, Davidson PT, Snider DE.
Tuberculosis in patients with HIV infection. N Engl J
Med 1991; 324: 1644–1650.
23. Edwards D, Kirkpatrick CH. The immunology of
Mycobacterial Disease. Am Rev Respir Dis 1986; 134:
1062–1071.
24. Dannenberg AM Jr. Cellular hypersentivity
and cellular immunity in the pathogenesis of tubercu-
losis: specificity, systemic and local nature, and
associated macrophage enzymes. Bacteriol Rev 1968;
32: 85–102.
25. Willians T, Hellewell P. Immunopharmacology of
Neutrophils, Academic Press, 1994.
26. Rich AR. The Pathogenesis of Tuberculosis, 2nd ed.
Springfield, Illinois: Charles C. Thomas, Publisher.
70 E. WERNECK-BARROSO ET AL.27. Slavin RE, Walsh TJ, Pollack AD. Late generalized
tuberculosis: a clinical pathologic analysis and compar-
ison of 100 cases in the preantibiotic and antibiotic
eras. Medicine 1980; 59: 352–366.
28. Grinsztejn B, Fandinho FCO, Veloso VG, Nogueira
AS, Fonseca LS, Werneck-Barroso E. Mycobacteremia
in patients with the acquired immunodeficiency syn-
drome. Arch Intern Med 1997; 157: 2359–2363.
29. Cooper AM, Dalton DK, Stewart TA, Grin JP,
Russell DG, Orme IM. Disseminated tuberculosis in
IFN-g gene-disrupted mice. J Exp Med 1993; 178:
2243–2248.
30. Flynn J, Chan J, Triebold KJ, Dalton DK, Stewart TA,
Bloom BR. An essential role for interferon-gamma in
resistance to Mycobacterium tuberculosis infection. J
Exp Med 1993; 178: 2249–2254.
31. Vijayan VK, Rectha AM, Jawahar MS, Sankaran K,
Prabhakar R. Pulmonary eosinophilia in pulmonary
tuberculosis. Chest 1992; 101: 1708–1709.32. Lucas S., Nelson M. Pathogenesis of tuberculosis in
Human Immunodeficiency Virus-Infected People In:
Bloom, B.R., ed. Tuberculosis: Pathogenesis, Protection
and Control. Washington, D.C: American Society for
Microbiology, 1994; pp 503–513.
33. Jagirdar J, Zagzag D. Pathology and insights into
pathogenesis of tuberculosis. In: WN Rom and S.
Garay, eds. Tuberculosis, New York: Little, Brown and
Company (Inc.), 1995; pp. 467.
34. Gachot B, Wol B, Clair B, Regier B. Severe
tuberculosis in patients with HIV infection. Intensive
Care Med 1990; 16: 491–493.
35. Masud T, Kemp E. Corticosteroids in treatment of
disseminated tuberculosis in patients with HIV infec-
tion. Brit Med J 1988; 296: 464–465.
36. Murray JF. HIV-associated tuberculosis: watch for it in
the ICU. Intensive Care Med. 1990; 16: 487–488.
